Filing Details

Accession Number:
0001179110-18-011049
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-31 19:00:49
Reporting Period:
2018-08-30
Accepted Time:
2018-08-31 19:00:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280600 Acceleron Pharma Inc XLRN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214938 F Kevin Mclaughlin 128 Sidney Street
Cambridge MA 02139
Svp, Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-30 12,500 $27.97 56,439 No 4 M Direct
Common Stock Disposition 2018-08-30 12,500 $54.00 43,939 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2018-08-30 12,500 $0.00 12,500 $27.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,300 2026-03-03 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.